Cytokinetics | CYTK - Ebitda

Stock Price
65.32
Daily Change
-0.16 -0.24%
Monthly
4.70%
Yearly
61.56%
Q2 Forecast
63.92

Cytokinetics reported $-277.18M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Amgen USD 5.14B 775M Dec/2025
Arca Biopharma USD -25.07M 5.23M Mar/2025
Bayer EUR 1.97B 457M Dec/2025
Biogen USD 573.2M 253.7M Dec/2025
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cytokinetics USD -277.18M 169.36M Sep/2025
Eisai JPY 30.1B 6.62B Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Exelixis USD 248.93M 28.02M Sep/2025
Geron USD -9.47M 1.92M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ligand Pharmaceuticals USD 150.32M 129.42M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 4.77B 1.11B Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026